Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Spencer

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Drugs|August 21, 2001
Gemtuzumab ozogamicinJ K McGavin, C M Spencer
Drugs & Aging|June 1, 1997
Mitoxantrone. A review of its pharmacology and clinical efficacy in the management of hormone-resistant advanced prostate cancerL R Wiseman, C M Spencer
Drugs|April 25, 2000
Miglitol: a review of its therapeutic potential in type 2 diabetes mellitusL J Scott, C M Spencer
Drugs|July 1, 1995
Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infectionsC M Spencer, K L Goa
Drugs & Aging|November 1, 1996
Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertensionS S Patel, C M Spencer
Drugs|December 1, 1996
Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast mediumC M Spencer, K L Goa
Drugs|January 1, 1997
DiacereinC M Spencer, M I Wilde
Drugs|May 1, 1994
Anagrelide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of thrombocythaemiaC M Spencer, R N Brogden
Drugs & Aging|November 1, 1995
Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectorisC J Dunn, C M Spencer
Drugs|September 1, 1996
Quinupristin-dalfopristinH M Bryson, C M Spencer
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Drugs|August 21, 2001
Gemtuzumab ozogamicinJ K McGavin, C M Spencer
Drugs & Aging|June 1, 1997
Mitoxantrone. A review of its pharmacology and clinical efficacy in the management of hormone-resistant advanced prostate cancerL R Wiseman, C M Spencer
Drugs|April 25, 2000
Miglitol: a review of its therapeutic potential in type 2 diabetes mellitusL J Scott, C M Spencer
Drugs|July 1, 1995
Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infectionsC M Spencer, K L Goa
Drugs & Aging|November 1, 1996
Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertensionS S Patel, C M Spencer
Drugs|December 1, 1996
Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast mediumC M Spencer, K L Goa
Drugs|January 1, 1997
DiacereinC M Spencer, M I Wilde
Drugs|May 1, 1994
Anagrelide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of thrombocythaemiaC M Spencer, R N Brogden
Drugs & Aging|November 1, 1995
Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectorisC J Dunn, C M Spencer
Drugs|September 1, 1996
Quinupristin-dalfopristinH M Bryson, C M Spencer
Pageof 8